Vaxess Technologies
Dennis is Chief Scientific Officer at TARIS Biomedical. Prior to joining TARIS, Dr. Giesing served as Chief Scientific Officer for Urigen Pharmaceuticals. For over 30 years, Dr. Giesing has served in a variety of senior scientific and leadership roles within large pharmaceutical companies, including Vice President, Global Drug Metabolism & Pharmacokinetics at Aventis, as well as other leadership roles at Hoechst Marion Roussel, Marion Merrell Dow and Marion Laboratories. He earned a B.S. in Chemistry and his Ph.D. in Biochemical Pharmacology from the University of Missouri, Kansas City.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Vaxess Technologies
Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. They are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.